Related Experiment Video
Updated: May 3, 2026

09:37
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
8.7K
AMD-Mamba: A Phenotype-Aware Multi-modal Framework for Robust AMD Prognosis
Puzhen Wu1, Mingquan Lin2, Qingyu Chen3
1Department of Population Health Sciences, Weill Cornell Medicine, New York, NY 10022, USA.
Summary
We developed AMD-Mamba, a new AI framework, and a novel biomarker to predict age-related macular degeneration (AMD) progression. This tool integrates imaging, genetic, and demographic data for earlier detection of high-risk patients.
Area of Science:
- Ophthalmology and Artificial Intelligence
- Biomedical Informatics
Background:
- Age-related macular degeneration (AMD) is a primary cause of irreversible vision loss, necessitating accurate prognosis for timely intervention.
- Current prognostic methods often focus on limited local features, potentially missing crucial disease progression patterns.
Purpose of the Study:
- To introduce AMD-Mamba, a novel multi-modal framework for AMD prognosis.
- To develop and validate a new AMD biomarker for improved early detection and risk stratification.
Main Methods:
- Developed AMD-Mamba, a multi-modal framework integrating color fundus images, genetic variants, and socio-demographic data.
- Employed a novel metric learning strategy using AMD severity scales for richer feature representation.
- Utilized Vision Mamba to fuse local and global image information, enhancing analysis beyond traditional CNNs.
- Implemented multi-scale fusion combining imaging and clinical variables at different resolutions.
Main Results:
- The proposed AMD biomarker demonstrated significant predictive power for AMD progression.
- AMD-Mamba achieved improved detection of high-risk AMD patients in early stages when combined with existing variables.
- Experimental validation on the AREDS dataset (45,818 images, 52 genetic variants, 3 socio-demographic variables from 2,741 subjects) confirmed the framework's efficacy.
Conclusions:
- AMD-Mamba offers a promising multi-modal approach for more precise AMD prognosis.
- The novel biomarker significantly contributes to identifying individuals at high risk for AMD progression.
- This framework facilitates proactive and personalized management strategies for AMD patients.
Related Concept Videos
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21

